These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1379385)

  • 1. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F; Haber E; Matsueda GR
    Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots.
    Liau CS; Haber E; Matsueda GR
    Thromb Haemost; 1987 Feb; 57(1):49-54. PubMed ID: 3590080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessibility of epitopes on fibrin clots and fibrinogen gels.
    Procyk R; Kudryk B; Callender S; Blombäck B
    Blood; 1991 Apr; 77(7):1469-75. PubMed ID: 1706954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S; Gaffney PJ
    Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid molecules: insights into plasminogen activator function.
    Runge MS; Bode C; Haber E; Quertermous T
    Mol Biol Med; 1991 Apr; 8(2):245-55. PubMed ID: 1806766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
    Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of fibrin polymerization with monoclonal antibodies.
    Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
    Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
    Hui KY; Haber E; Matsueda GR
    Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D
    Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.